INCY vs ITIC · P/E 14, rev $5.14B vs P/E 12, rev $150.5M
Incyte Corporation (INCY) versus Investors Title Company (ITIC) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Investors Title Company (ITIC) is a insurance - specialty company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported ITIC revenue for 2026-06-30 was $150.5M. Net income was $20.7M. ITIC currently screens at market cap $437.7M and trailing P/E 11.5.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. ITIC currently screens at market cap $437.7M and trailing P/E 11.5.
Not investment advice. Open the INCY and ITIC stock pages for the full models.
Not investment advice.